What are biomarkers?

The FDA defines biomarkers as:

"A Characteristic that is objectively measured and evaluated as an indicator of normal biologic or pathogenic processes or pharmacologic response to a drug."

Why are biomarkers important to drug development?

The drug development industry and regulators are interested in the use of biomarkers to aid identification of signals for safety and efficacy. Incorporating a biomarker strategy through all phases of development can lead to quicker decisions and improved commercial viability.

Why are biomarkers important to Covance?

Covance seeks to provide our clients with market leading services which can deliver on the promise of biomarkers. Our clients have scientifically diverse biomarker needs from discovery to support of global clinical trials and use of biomarkers for segmentation of patient populations. The Biomarker Center of Excellence (COE) enables our clients to benefit from Covance’s broad knowledge base and scientific expertise.